Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer

BACKGROUND: Studies on the application of targeted therapies for patients with non‐small cell lung cancer (NSCLC) who harbor rare genetic mutations are ongoing. In the present study, we investigated the real‐world data of NSCLC patients who harbor rare mutations. METHODS: We retrospectively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Yeon, Kim, Young Chul, Lee, Kye Young, Lee, Sung Yong, Lee, Shin Yup, Lee, Min Ki, Lee, Jeong Eun, Jang, Seung Hun, Jang, Tae‐Won, Choi, Chang Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807245/
https://www.ncbi.nlm.nih.gov/pubmed/34881519
http://dx.doi.org/10.1111/1759-7714.14266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807245/
https://www.ncbi.nlm.nih.gov/pubmed/34881519
http://dx.doi.org/10.1111/1759-7714.14266

Ejemplares similares